2020
DOI: 10.1136/bmj.l6923
|View full text |Cite
|
Sign up to set email alerts
|

Is there a place for intra-articular corticosteroid injections in the treatment of knee osteoarthritis?

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
20
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 23 publications
(20 citation statements)
references
References 15 publications
0
20
0
Order By: Relevance
“…Further, it is unknown how many patients have avoided total knee replacement by judicious use of IACS injections over many years, so long-term studies with sensitive MRI end points are required to determine if effects on pertinent joint and many years. If these complications are rare, were already present as causes of pain before the injection, or would have occurred irrespective of the intervention, then preinjection imaging would not be needed (45).…”
Section: Should There Be Imaging Before Steroid Injections?mentioning
confidence: 99%
“…Further, it is unknown how many patients have avoided total knee replacement by judicious use of IACS injections over many years, so long-term studies with sensitive MRI end points are required to determine if effects on pertinent joint and many years. If these complications are rare, were already present as causes of pain before the injection, or would have occurred irrespective of the intervention, then preinjection imaging would not be needed (45).…”
Section: Should There Be Imaging Before Steroid Injections?mentioning
confidence: 99%
“…Godlee, editor-in-chief of the British Medical Journal (BMJ), referencing several articles in a recent issue, concluded that ''new research published in the BMJ casts doubt on the benefits of [masking]'' of clinical studies that can add cost and compromise patient safety, in favor of large studies with appropriate randomization. [6][7][8][9] Goldstein and Walensky highlight the issue of lack of parity in enrolling women in clinical trials, especially those of anti-HIV treatments. 10…”
Section: Regulatory Government and Pharmaceutical Industrymentioning
confidence: 99%
“…Due to the background of MSK advanced practice roles, there is a risk that some clinicians may focus too heavily on biomedical factors in terms of requesting investigations, non‐medical prescribing and injection therapy. MSK conditions can be over investigated and the efficacy of an increasing number of surgical procedures and injections is being questioned (Orchard, 2020). Therefore while these are important skills they are not essential and the emphasis for the FCP role should be on first line management focusing on normalising age‐related findings, lifestyle factors and identifying what matters most to the patients (Lewis, Cook, Hoffman, & O'Sullivan, 2020; Stenner, Hammond, & Palmer, 2018).…”
Section: Population Health Focusmentioning
confidence: 99%